VanEck Morningstar Wide Moat Value ETF (MVAL)
BATS: MVAL · Real-Time Price · USD
36.86
+0.08 (0.22%)
Dec 5, 2025, 4:00 PM EST - Market closed
0.22% (1D)
| Assets | $5.46M |
| Expense Ratio | 0.49% |
| PE Ratio | 18.27 |
| Shares Out | 150,000 |
| Dividend (ttm) | $0.31 |
| Dividend Yield | 0.85% |
| Ex-Dividend Date | Dec 23, 2024 |
| Payout Ratio | 15.52% |
| 1-Year Return | +8.70% |
| Volume | 66 |
| Open | 36.86 |
| Previous Close | 36.78 |
| Day's Range | 36.86 - 36.86 |
| 52-Week Low | 27.40 |
| 52-Week High | 36.88 |
| Beta | n/a |
| Holdings | 41 |
| Inception Date | Mar 26, 2024 |
About MVAL
Fund Home PageThe VanEck Morningstar Wide Moat Value ETF (MVAL) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a modified equal-weighted index of 30 to 60 value-oriented US stocks that Morningstar determines to be attractively priced and have sustainable competitive advantages. MVAL was launched on Mar 26, 2024 and is issued by VanEck.
Asset Class Equity
Category Large Value
Region North America
Stock Exchange BATS
Ticker Symbol MVAL
ETF Provider VanEck
Index Tracked Morningstar US Broad Value Wide Moat Focus Index
Top 10 Holdings
43.73% of assets| Name | Symbol | Weight |
|---|---|---|
| Thermo Fisher Scientific Inc. | TMO | 5.46% |
| Merck & Co., Inc. | MRK | 5.25% |
| Danaher Corporation | DHR | 4.83% |
| United Parcel Service, Inc. | UPS | 4.55% |
| Bristol-Myers Squibb Company | BMY | 4.49% |
| NIKE, Inc. | NKE | 4.04% |
| Zimmer Biomet Holdings, Inc. | ZBH | 3.96% |
| The Boeing Company | BA | 3.77% |
| Constellation Brands, Inc. | STZ | 3.71% |
| The Campbell's Company | CPB | 3.67% |
News
Volta Finance Limited - Half-year report
MVAL and MGRO join MOAT and other ETFs in suite of funds built around Morningstar's proven strategy of identifying quality companies with distinct economic moats trading at attractive valuations.
Other symbols: MGRO
1 year ago - GlobeNewsWire